CXXC5 is a negative-feedback regulator of the Wnt/β-catenin pathway involved in osteoblast differentiation

Cell Death and Differentiation

Volumn 22, Issue 6, 2015, Pages 912-920

  Kim, H Y ^a   Yoon, J Y ^a   Yun, J H ^a   Cho, K W ^a   Lee, S H ^a   Rhee, Y M ^b   Jung, H S ^a   Lim, H J ^c   Lee, H ^c   Choi, J ^a   Heo, J N ^c   Lee, W ^a   No, K T ^a   Min, D ^a,d   Choi, K Y ^a  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Korea Research Institute of Chemical Technology   (South Korea)

^d Pusan National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CHEMOKINE RECEPTOR CXCR5; WNT PROTEIN;

ANIMAL; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; GENETICS; HUMAN; KNOCKOUT MOUSE; METABOLISM; MOUSE; OSTEOBLAST; PHYSIOLOGY; WNT SIGNALING PATHWAY;

ANIMALS; BETA CATENIN; CELL DIFFERENTIATION; CELL LINE; HUMANS; MICE; MICE, KNOCKOUT; OSTEOBLASTS; RECEPTORS, CXCR5; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84939946427     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2014.238     Document Type: Article

References (24)

1. Eriksen EF. Cellular mechanisms of bone remodeling. Rev Endocr Metab Disord 2010; 11: 219-227.
2. Long F. Building strong bones: molecular regulation of the osteoblast lineage. Nat Rev Mol Cell Biol 2012; 13: 27-38.
3. Rachner TD, Khosla S, Hofbauer LC. Osteoporosis: now and the future. Lancet 2011; 377: 1276-1287.
4. Regard JB, Zhong Z, Williams BO, Yang Y. Wnt signaling in bone development and disease: making stronger bone with Wnts. Cold Spring Harb Perspect Biol 2012; 4: 1-17.
5. Hoeppner LH, Secreto FJ, Westendorf JJ. Wnt signaling as a therapeutic target for bone diseases. Expert Opin Ther Targets 2009; 13: 485-496.
6. Ravasi T, Huber T, Zavolan M, Forrest A, Gaasterland T, Grimmond S et al. Systematic characterization of the zinc-finger-containing proteins in the mouse transcriptome. Genome Res 2003; 13: 1430-1442.
7. Pendino F, Nguyen E, Jonassen I, Dysvik B, Azouz A, Lanotte M et al. Functional involvement of RINF, retinoid-inducible nuclear factor (CXXC5), in normal and tumoral human myelopoiesis. Blood 2009; 113: 3172-3181.
8. Kim HY, Yang DH, Shin SW, Kim MY, Yoon JH, Kim S et al. CXXC5 is a transcriptional activator of Flk-1 and mediates bone morphogenic protein-induced endothelial cell differentiation and vessel formation. FASEB J 2014; 28: 615-626.
9. Andersson T, Södersten E, Duckworth JK, Cascante A, Fritz N, Sacchetti P et al. CXXC5 is a novel BMP4-regulated modulator of Wnt signaling in neural stem cells. J Biol Chem 2009; 284: 3672-3681.
10. Hino S, Kishida S, Michiue T, Fukui A, Sakamoto I, Takada S et al. Inhibition of the Wnt signaling pathway by Idax, a novel Dvl-binding protein. Mol Cell Biol 2001; 21: 330-342.
11. Qin C, D'Souza R, Feng JQ. Dentin matrix protein 1 (DMP1): new and important roles for biomineralization and phosphate homeostasis. J Dent Res 2007; 86: 1134-1141.
12. Bonewald LF, Johnson ML. Osteocytes, mechanosensing and Wnt signaling. Bone 2008; 42: 606-615.
13. Stuart AJ, Smith DA. Use of the fluorochromes xylenol orange, calcein green, and tetracycline to document bone deposition and remodeling in healing fractures in chickens. Avian Dis 1992; 36: 447-449.
14. Wang D, Christensen K, Chawla K, Xiao G, Krebsbach PH, Franceschi RT et al. Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J Bone Miner Res 1999; 14: 893-903.
15. Reinhold MI, Naski MC. Direct interactions of Runx2 and canonical Wnt signaling induce FGF18. J Biol Chem 2007; 282: 3653-3663.
16. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT et al. Identification of c-MYC as a target of the APC pathway. Science 1998; 281: 1509-1512.
17. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 1999; 96: 5522-5527.
18. London TB, Lee HJ, Shao Y, Zheng J. Interaction between the internal motif KTXXXI of Idax and mDvl PDZ domain. Biochem Biophys Res Commun 2004; 322: 326-332.
19. Matsushita M, Matsui H. Protein transduction technology. J Mol Med 2005; 83: 324-328.
20. Reynolds JJ, Minkin C, Morgan DB, Spycher D, Fleisch H. The effect of two diphosphonates on the resorption of mouse calvaria in vitro. Calcif Tissue Res 1972; 10: 302-313.
21. Canalis E, Giustina A, Bilezikian JP. Mechanisms of anabolic therapies for osteoporosis. N Engl J Med 2007; 357: 905-916.
22. Li X, Zhang Y, Kang H, Liu W, Liu P, Zhang J et al. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem 2005; 280: 19883-19887.
23. Vashishth D, Verborgt O, Divine G, Schaffler MB, Fyhrie DP. Decline in osteocyte lacunar density in human cortical bone is associated with accumulation of microcracks with age. Bone 2000; 26: 375-380.
24. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987; 2: 595-610.